A phase 3, open-label trial evaluating the safety, tolerability, and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan

Trial Profile

A phase 3, open-label trial evaluating the safety, tolerability, and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Aug 2012

At a glance

  • Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Most Recent Events

    • 25 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top